Page last updated: 2024-08-22

cladribine and Agnogenic Myeloid Metaplasia

cladribine has been researched along with Agnogenic Myeloid Metaplasia in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (33.33)18.2507
2000's5 (55.56)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahm, AEA; Dybedal, I; Habberstad, AH; Randen, U; Spetalen, S; Tjønnfjord, GE; Tran, HTT1
Dedic, K; Zák, P2
Araki, H; Kuribayashi, K; Kuroda, H; Matsunaga, T; Murase, K; Niitsu, Y; Terui, T1
Faoro, LN; Mesa, RA; Tefferi, A1
Fenk, R; Gattermann, N; Germing, U; Haas, R; Kündgen, A; Strupp, C1
Li, CY; Silverstein, MN; Tefferi, A1
Abramson, N; Marks, AR1
Reilly, JT1

Reviews

1 review(s) available for cladribine and Agnogenic Myeloid Metaplasia

ArticleYear
Pathogenesis and management of idiopathic myelofibrosis.
    Bailliere's clinical haematology, 1998, Volume: 11, Issue:4

    Topics: Anemia; Animals; Bone Marrow; Bone Marrow Transplantation; Cladribine; Combined Modality Therapy; Disease Models, Animal; Erythropoietin; Growth Substances; Hematopoietic Stem Cells; Humans; Hydroxyurea; Interferon-alpha; Karyotyping; Megakaryocytes; Mice; Polyethylene Glycols; Primary Myelofibrosis; Prognosis; Recombinant Proteins; Splenectomy; Stromal Cells; Thrombopoietin; Vitamin D

1998

Other Studies

8 other study(ies) available for cladribine and Agnogenic Myeloid Metaplasia

ArticleYear
Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.
    Journal of medical case reports, 2018, Apr-24, Volume: 12, Issue:1

    Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Marrow; Cladribine; Disease Progression; Fatal Outcome; Humans; Janus Kinase 2; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Leukopenia; Male; Neutropenia; Oral Ulcer; Polycythemia Vera; Primary Myelofibrosis; Splenomegaly; Thrombocytopenia

2018
Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
    Neoplasma, 2004, Volume: 51, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Primary Myelofibrosis

2004
[Bone marrow fibrosis during therapy of hairy cell leukemia].
    Ceskoslovenska patologie, 2004, Volume: 40, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Primary Myelofibrosis

2004
[Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:6

    Topics: Antineoplastic Agents; Cladribine; Drug Administration Schedule; Erythema Nodosum; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Pancytopenia; Primary Myelofibrosis; Remission Induction; Splenomegaly

2004
Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia.
    European journal of haematology, 2005, Volume: 74, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Hematologic Diseases; Hepatomegaly; Humans; Male; Middle Aged; Palliative Care; Primary Myelofibrosis; Retrospective Studies; Splenectomy

2005
Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide.
    Leukemia research, 2005, Volume: 29, Issue:8

    Topics: Aged; Cladribine; Humans; Leukemia, Hairy Cell; Male; Primary Myelofibrosis; Remission Induction; Thalidomide; Treatment Outcome

2005
2-Chlorodeoxyadenosine treatment after splenectomy in patients who have myelofibrosis with myeloid metaplasia.
    British journal of haematology, 1997, Volume: 99, Issue:2

    Topics: Anemia; Cladribine; Female; Follow-Up Studies; Hepatomegaly; Humans; Leukocytosis; Male; Primary Myelofibrosis; Splenectomy; Thrombocytosis; Treatment Outcome

1997
Effect of 2-CDA on thrombocytopenia in myelofibrosis.
    British journal of haematology, 1998, Volume: 102, Issue:2

    Topics: Cladribine; Humans; Immunosuppressive Agents; Primary Myelofibrosis; Thrombocytopenia

1998